Company Analysis
Sign in

Sol-Gel Technologies Ltd. (SLGL)

Nasdaq: SLGL · Pharmaceutical Preparations · filing with the SEC since 2016
Full chart Alerts Compare
Grade6.3
◀ Past 6.6● Present 6.4▶ Future 6.1
2 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

40 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Sol-Gel Technologies Ltd.’s names, not what it holds today.

Patents granted
40
40 utility, 1976 to Dec 31, 2025
Granted in 2025
2
Against 8 in 2024 and 3 in 2023
Applications published
89
1 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'09'10'11'12'13'14'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals17
Organic fine chemistry2
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Sol-Gel Technologies Ltd. its own name
IL, as the owner printed on each patent. 1 more under the same name are not counted (printed in GB)
40 granted
70 published
Sol-Gel Technologies Ltd. its own name
named as the applicant on its applications, in IL. 1 more under the same name are not counted (printed in US)
0 granted
19 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
May 13, 202512,295,935Method for therapeutic treatment of rosaceaPharmaceuticalsSol-Gel Technologies Ltd.
Mar 25, 202512,257,348Stabilized microcapsules, method of their preparation and uses thereofPharmaceuticalsSol-Gel Technologies Ltd.
Dec 3, 202412,156,946Method for preparing particles comprising metal oxide coating and particles with metal oxide coatingPharmaceuticalsSol-Gel Technologies Ltd.
Nov 5, 202412,133,919Stabilized microcapsules, method of their preparation and uses thereofPharmaceuticalsSol-Gel Technologies Ltd.
Aug 27, 202412,070,629Core stabilized microcapsules, method of their preparation and uses thereofPharmaceuticalsSol-Gel Technologies Ltd.
Aug 6, 202412,053,546Stabilized topical formulations containing core-shell microcapsulesPharmaceuticalsSol-Gel Technologies Ltd.
May 21, 202411,986,456Method for treatment of rosaceaPharmaceuticalsSol-Gel Technologies Ltd.
Jan 23, 202411,877,997Method for providing early onset of action in the treatment of rosaceaPharmaceuticalsSol-Gel Technologies Ltd.
Jan 9, 202411,865,208Pharmaceutical compositions comprising silica microspheresPharmaceuticalsSol-Gel Technologies Ltd.
Jan 9, 202411,865,100Method for treatment of rosacea in patients aged 65 years and olderPharmaceuticalsSol-Gel Technologies Ltd.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Nov 6, 20252025/0339408TREATMENT AND PREVENTION OF BASAL CELL CARCINOMA WITH TOPICAL COMPOSITION COMPRISING PATIDEGIBPharmaceuticalsSol-Gel Technologies Ltd.
Aug 15, 20242024/0269121METHODS OF REDUCING ACNE AND ROSACEA RELAPSE RATE AND SEVERITYPharmaceuticalsSol-Gel Technologies Ltd.
Dec 21, 20232023/0404917RUXOLITINIB OR DEUTERATED RUXOLITINIB COMPOSITION AND USES THEREOFPharmaceuticalsSol-Gel Technologies Ltd.
Dec 7, 20232023/0390291TREATMENT OF SKIN DISORDERS WITH COMPOSITIONS COMPRISING AN EGFR INHIBITORPharmaceuticalsSol-Gel Technologies Ltd.
Nov 16, 20232023/0364050METHOD FOR TREATMENT OF ROSACEA INCLUDING PATIENT REPORTED OUTCOMES THEREOFPharmaceuticalsSol-Gel Technologies Ltd.
Nov 9, 20232023/0357113TAPINAROF POLYMORPHSOrganic fine chemistrySol-Gel Technologies Ltd.
Nov 2, 20232023/0346716TREATMENT OF SKIN DISORDERS WITH TOPICAL TAPINAROF COMPOSITIONSPharmaceuticalsSol-Gel Technologies Ltd.
Oct 26, 20232023/0338306STABILIZED MICROCAPSULES, METHOD OF THEIR PREPARATION AND USES THEREOFPharmaceuticalsSol-Gel Technologies Ltd.
Oct 5, 20232023/0310395TOPICAL ROFLUMILAST COMPOSITIONS AND USES THEREOFPharmaceuticalsSol-Gel Technologies Ltd.
Aug 10, 20232023/0248687METHOD FOR THERAPEUTIC TREATMENT OF ROSACEAPharmaceuticalsSol-Gel Technologies Ltd. · patent 12,295,935 granted from it
What it applied for, 2024 to 2025: Pharmaceuticals 2.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton SLGL · research, not advice